HealthStream Inc. (HSTM) is an American company that provides learning and performance management solutions to the healthcare industry. With headquarters in Nashville, Tennessee, and established in 1990, HealthStream's primary mission is to improve patient outcomes through the development of the healthcare workforce.
HealthStream operates in two main segments: Workforce Solutions and Provider Solutions. Through its Workforce Solutions, the company offers a wide range of solutions to help healthcare organizations meet their clinical and business goals. These solutions encompass a broad spectrum ranging from talent management, training & learning management, clinical development, competency management, and simulation-based training, to performance assessments and management. They help healthcare institutions to effectively onboard new hires, retain clinical staff, remain compliant with regulations, and improve business operations.
The Provider Solutions segment, on the other hand, provides credentialing, privileging, call center, and enrollment services to healthcare providers. HealthStream’s credentials verification organization (CVO) services provide the primary source verification required to meet the credentialing needs of healthcare providers.
HealthStream is a leading provider in its respective fields with its products and services used by around 4.9 million healthcare professionals in more than 70% of U.S. hospitals. It caters to a wide range of clients - from big healthcare systems to small individual practice.
Despite the challenges brought by the COVID-19 pandemic, HealthStream has remained resilient and stood as a vital partner for healthcare providers, offering essential training such as COVID related courses including ventilator use, personal protective equipment use and infection control, allowing healthcare professionals to swiftly respond to the global health crisis.
Moreover, over the years of operation HealthStream has been involved in various strategic acquisitions, expanding on its core competencies and broadening its service offerings, with the aim of providing comprehensive blended learning solutions that can improve patient care and reduce healthcare costs.
Conclusively, HealthStream’s contribution to the healthcare sector is not only invaluable but also innovative, making them not just a key player but an essential partner in shaping the future of healthcare. The essence of HealthStream’s mission goes beyond just providing solutions; it is cultural, aiming at nurturing a competent and knowledgeable healthcare workforce, ultimately enhancing patient outcomes. It has been their continuous dedication to service and quality that has made HealthStream a trusted name in healthcare.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
HealthStream is entering its Q3 report with a stock rally but a cautious outlook from management regarding slower growth and profitability due to increased spending. The report will test whether the market has accurately priced in both the past acceleration and the planned investment-driven pause. Investors will closely watch revenue growth, product mix performance, and remaining performance obligations to determine if the spending translates into sustainable long-term growth.
HealthStream (HSTM) is scheduled to release its Q3 2026 earnings after market close on Monday, November 2nd, with analysts expecting $0.1567 EPS on $82.24 million in revenue. The company surpassed expectations in the previous quarter, reporting $0.23 EPS and $83.73 million in revenue. Shares opened at $35.16, near their 52-week high, and the company maintains an average "Hold" rating from analysts with a $27.00 price target.
HealthStream Director Linda Rebrovick sold 12,000 shares of HSTM stock for $420,000 at an average price of $35.00, reducing her direct ownership by 23.38%. The transaction was executed under a Rule 10b5-1 trading plan, and comes as HealthStream's shares are trading near a one-year high. The company recently exceeded quarterly earnings and revenue estimates, while analysts maintain an overall "Hold" rating with an average price target of $27.
Argus has raised its target price for HealthStream, Inc. (HSTM) to $37.00. The company, which provides workforce and provider solutions for healthcare organizations, is currently priced at $33.13. This update comes from a quantitative report dated October 14, 2026.
Wall Street Zen downgraded HealthStream (NASDAQ:HSTM) from "Buy" to "Hold," aligning with the broader analyst consensus. The company recently reported strong quarterly earnings, beating both EPS and revenue estimates. Despite a stock sale by CEO Robert Frist Jr., insiders maintain a significant stake, and institutional investors hold a majority of the company's shares.
Freedom Capital upgraded HealthStream (NASDAQ:HSTM) stock to a "Hold" rating. The company's shares opened at $33.65, near its 52-week high, and it recently surpassed quarterly earnings and revenue estimates. Despite institutional ownership and significant insider selling by the CEO, the average analyst rating for HSTM remains "Hold" with a price target of $27.00.
HealthStream (HSTM) has seen its stock price rise significantly, leading to renewed interest in its valuation. One common analysis suggests the healthcare software company is 16% undervalued, with a fair value of $40.00 per share compared to its current price of $33.75, backed by strong subscription revenue, no debt, and healthy free cash flow. However, another perspective based on its P/E ratio indicates that the stock trades at a premium compared to its industry peers, suggesting that potential disappointments could impact investor sentiment.
Copeland Capital Management LLC has reduced its stake in HealthStream, Inc. (NASDAQ:HSTM) by 2.5% during the third quarter, selling 31,148 shares but still retaining over 1.2 million shares valued at $36.2 million. Despite this, institutional investors collectively own 69.58% of the company. HealthStream reported strong quarterly earnings and revenue, exceeding analyst expectations, and pays an annualized dividend of $0.14.